These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 1543834)

  • 1. Tumors of low malignant potential.
    Leake JF
    Curr Opin Obstet Gynecol; 1992 Feb; 4(1):81-5. PubMed ID: 1543834
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Management of early ovarian cancer: germ cell and sex cord-stromal tumors.
    Gershenson DM
    Gynecol Oncol; 1994 Dec; 55(3 Pt 2):S62-72. PubMed ID: 7530680
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Current management of malignant germ cell tumor of the ovary.
    Aziz MF
    Gan To Kagaku Ryoho; 1995 Aug; 22 Suppl 3():262-76. PubMed ID: 7661594
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ovarian epithelial tumors of low malignant potential.
    Chien RT; Rettenmaier MA; Micha JP; DiSaia PJ
    Surg Gynecol Obstet; 1989 Aug; 169(2):143-6. PubMed ID: 2756462
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gynecological malignancies.
    Schaebler DL; Schilder RJ; Young RC
    Cancer Chemother Biol Response Modif; 1996; 16():564-91. PubMed ID: 8639401
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Analysis of treatment failures and survival of patients with fallopian tube carcinoma: a cooperation task force (CTF) study.
    Gadducci A; Landoni F; Sartori E; Maggino T; Zola P; Gabriele A; Rossi R; Cosio S; Fanucchi A; Tisi G
    Gynecol Oncol; 2001 May; 81(2):150-9. PubMed ID: 11330942
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Is there a role for second-look laparotomy in the management of malignant germ cell tumors of the ovary? Experience at Institut Gustave Roussy.
    Culine S; Lhomme C; Michel G; Leclere J; Duvillard P; Droz JP
    J Surg Oncol; 1996 May; 62(1):40-5. PubMed ID: 8618400
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term survival in advanced ovarian cancer after cytoreduction and chemotherapy treatment.
    Del Campo JM; Felip E; Rubio D; Vidal R; Bermejo B; Colomer R; Zanon V
    Gynecol Oncol; 1994 Apr; 53(1):27-32. PubMed ID: 8175018
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Germ cell tumors of the ovary.
    Pectasides D; Pectasides E; Kassanos D
    Cancer Treat Rev; 2008 Aug; 34(5):427-41. PubMed ID: 18378402
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Second-look laparotomy in ovarian germ cell tumors: the gynecologic oncology group experience.
    Williams SD; Blessing JA; DiSaia PJ; Major FJ; Ball HG; Liao SY
    Gynecol Oncol; 1994 Mar; 52(3):287-91. PubMed ID: 8157184
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Ovarian carcinoma: current therapeutic aspects. A review].
    Buser K; Hänggi W; Greiner R; Schatzmann E
    Schweiz Med Wochenschr; 1990 Nov; 120(44):1617-32. PubMed ID: 2251477
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epithelial ovarian carcinoma: principles of primary surgery.
    Hoskins WJ
    Gynecol Oncol; 1994 Dec; 55(3 Pt 2):S91-6. PubMed ID: 7835815
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Small cell of the ovary, hypercalcemic type -- analysis of combined experience and recommendation for management. A GCIG study.
    Harrison ML; Hoskins P; du Bois A; Quinn M; Rustin GJ; Ledermann JA; Baron-Hay S; Friedlander ML
    Gynecol Oncol; 2006 Feb; 100(2):233-8. PubMed ID: 16321429
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Second-look laparotomy in stage III epithelial ovarian cancer: clinical variables associated with disease status.
    Berek JS; Hacker NF; Lagasse LD; Poth T; Resnick B; Nieberg RK
    Obstet Gynecol; 1984 Aug; 64(2):207-12. PubMed ID: 6539884
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The postoperative therapy of epithelial ovarian carcinoma. Has systemic cytostasis replaced percutaneous radiation?].
    Souchon R; Cwiekala M
    Strahlenther Onkol; 1995 Nov; 171(11):630-40. PubMed ID: 7502226
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Adjuvant chemotherapy of cancer of the ovary].
    Cappelaere P; Horner-Vallet D; Demaille A
    Bull Cancer; 1984; 71(4):363-9. PubMed ID: 6498348
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Ovarian cancers--a solution within reach?].
    Haller U; Lütolf UM; Jungi WF
    Schweiz Med Wochenschr; 1983 Sep; 113(36):1300-5. PubMed ID: 6635629
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Adjuvant therapy of malignant ovarian tumors after organ preserving surgery].
    Schröder W
    Zentralbl Gynakol; 1996; 118(10):565-70. PubMed ID: 8912476
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The value of cytoreductive second-look surgery in advanced epithelial ovarian carcinoma].
    Sevelda P; Barrada M; Vavra N; Denison U; Schmidl S; Genger H; Salzer H
    Wien Klin Wochenschr; 1990 Aug; 102(15):441-3. PubMed ID: 2402929
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic significance of DNA content in epithelial ovarian cancer.
    Gajewski WH; Fuller AF; Pastel-Ley C; Flotte TJ; Bell DA
    Gynecol Oncol; 1994 Apr; 53(1):5-12. PubMed ID: 8175021
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.